Western Pennsylvania Guide to Good Health
Departments Health Links Calendar Archived Issues Media Kit Contact Us
  Senior Care Senior Living Camps & Activities for Special Needs Children Ask the Expert  
  Article    
 

New Treatment Available for End-stage Macular Degeneration
By Erica A. Hacker, O.D.

Implantable telescopic lens

Imagine the heartbreak for someone who gradually loses the ability to see her grandchildren, husband and the people who mean the most to her. Now imagine her joy when she can see them again. Thanks to a groundbreaking new treatment program, this dream can now be a reality for patients with end-stage age related macular degeneration (AMD), the leading cause of blindness in older Americans.

The comprehensive treatment program has been designed by CentraSight and is the only treatment program available in the United States that uses an FDA approved implantable telescopic lens. In the Pittsburgh area, the treatment program is available through a multidisciplinary team including Blind & Vision Rehabilitation Services of Pittsburgh, Dr. Viki Christopoulos and Dr. Pamela Rath.

More than 15 million Americans are affected by some form of macular degeneration, which attacks the macula of the eye, where one's sharpest central vision occurs. Although it does not cause complete blindness, patients with end-stage AMD have a central blind spot, or missing area, in their vision. This vision loss makes it difficult or impossible to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care.

The CentraSight treatment program uses a tiny telescope that is implanted inside the eye. Smaller than a pea, the telescope implant magnifies objects that would normally be seen in one's "straight ahead" vision. This image is projected onto the healthy retina in the back of the eye not affected by the disease.

Potential patients undergo medical and vision evaluations to determine whether they may be a good candidate. After an eye surgeon implants the telescope in an outpatient procedure, the patient then works with vision specialists at Blind & Vision Rehab to learn how to use their new vision in their everyday activities.

The telescope implant is not a cure. Patients must meet age and cornea health requirements to be considered a good candidate.

For more information on the telescope implant and who qualifies for the treatment, contact Dr. Erica Hacker, optometrist in the Low Vision Department at Blind & Vision Rehabilitation Services of Pittsburgh, at (412) 368-4400. Additional details are available at www.bvrspittsburgh.org/ telescope-implant.

Return to Top



Current Issue of Western Pennsylvania Guide to Good Health AdvertiseSubscribe for FREE 2016 Annual Healthcare Guide Download a PDF version
Subscribe to GTGH

Focus

Painting With A Twist

Doterra

Legacy Medical Centers

Community Life

WR Cameron Wellness Center

Largest Selection of Diabetic Shoes

Medicare Specialists of Pittsburgh

Blind and Rehabilitation Services of Pittsburgh

Western Pennsylvania School for Blind Children

New Story

East End Food Coop

Life Pittsburgh

Elderly Housing

Reserve This Space | Call 412-835-5796 or email goodhealthmag@aol.com


Western Pennsylvania Guide to Good Health. All rights reserved.


Send email to goodhealthmag@aol.com